incretin mimetic agents glp 1 receptor agonists Letter: Association Between Mimetics and Medullary Thyroid Cancer The mechanisms of dual incretin
Description
may be attributable to differences in study populations, GLP-1 type, and the extent of weight loss achieved
Graaf Cd, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, et al
Check your coverage See whether your GLP-1 medication is covered by your insurance plan
doi: 10.3389/fendo.2013.00103
A hormone in its venom is like a GLP-1 receptor agonist (GLP-1RA) as it regulates blood sugar levels and modulates appetite by triggering insulin release
That distinction is clinically important because it removes many of the limitations associated with peptide medications
